Related Experiment Video

Updated: Jun 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Cancer gene therapy with oncolytic adenoviruses

K Guse1, A Hemminki

  • 1Cancer Gene Therapy Group, Molecular Cancer Biology Program & Transplantation Laboratory, Haartman Institute, University of Helsinki, and HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|September 29, 2009
PubMed

Insights

Oncolytic adenoviruses show promise for cancer gene therapy, offering a safe treatment option. Strategies to enhance tumor targeting and replication are crucial for improving their efficacy against metastatic cancers.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Metastatic cancer is challenging to treat, often lacking curative options and causing significant side effects.
  • Gene therapy, particularly oncolytic adenoviruses, presents a promising targeted approach for various tumors.
  • Current clinical trials indicate oncolytic adenoviruses are safe but require improved antitumor efficacy.

Purpose of the Study:

  • To review strategies for enhancing oncolytic adenovirus efficacy in cancer treatment.
  • To focus on methods improving tumor cell transduction and selective replication.
  • To discuss approaches for arming viruses with therapeutic transgenes and overview clinical applications.

Main Methods:

  • Review of existing literature on oncolytic adenoviruses.
  • Analysis of targeting strategies for improved tumor cell transduction.
  • Evaluation of methods for enhancing cancer cell-selective replication.
  • Discussion of transgene-based therapeutic strategies.
  • Overview of clinical trial data and approaches.

Main Results:

  • Oncolytic adenoviruses demonstrate safety in clinical trials.
  • Efficacy requires improvement for widespread clinical adoption.
  • Targeting strategies can enhance tumor cell transduction and selective replication.
  • Arming viruses with transgenes offers potential for increased antitumor activity.

Conclusions:

  • Oncolytic adenoviruses are a safe platform for cancer gene therapy.
  • Enhancing tumor targeting, replication, and therapeutic payload are key to improving efficacy.
  • Further development is needed to establish oncolytic adenoviruses as a viable cancer treatment alternative.

More Related Videos

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...